A randomized, double-blind, placebo-controlled, three-arm, Parallel group, multi-centric, clinical study to evaluate the Therapeutic Bio equivalence of two Tacrolimus 0.1% topical Ointment formulations in adult patients with moderate to Severe Atopic Dermatitis - NA

Trial Profile

A randomized, double-blind, placebo-controlled, three-arm, Parallel group, multi-centric, clinical study to evaluate the Therapeutic Bio equivalence of two Tacrolimus 0.1% topical Ointment formulations in adult patients with moderate to Severe Atopic Dermatitis - NA

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Sponsors Intas Pharmaceuticals
  • Most Recent Events

    • 26 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top